Publications of Patrizio Lancellotti
Bookmark and Share    
Full Text
See detailChronic ischemic mitral regurgitation
DULGHERU, Raluca Elena ULg; LANCELLOTTI, Patrizio ULg

in Applied echocardiography in coronary artery disease (in press)

Detailed reference viewed: 37 (6 ULg)
Full Text
See detailInvited Commentary
Lancellotti, Patrizio ULg; Nchimi Longang, Alain ULg

in Annals of Thoracic Surgery (2017), 103(1), 81-82

Detailed reference viewed: 9 (0 ULg)
Full Text
See detailProspective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia.
VROONEN, Laurent ULg; Lancellotti, Patrizio ULg; Garcia, Monica Tome et al

in Endocrine (2016)

Since the 1990's cabergoline has been the treatment of choice in prolactinoma, as it permits rapid and effective hormonal and tumor control in most cases. Evidence of cardiac valvulopathy was demonstrated ... [more ▼]

Since the 1990's cabergoline has been the treatment of choice in prolactinoma, as it permits rapid and effective hormonal and tumor control in most cases. Evidence of cardiac valvulopathy was demonstrated in Parkinson's disease patients treated with dopamine agonists. Retrospective studies in prolactinoma patients treated with cabergoline at lower doses did not show such an effect. However, few prospective data with long-term follow-up are available. The aim of this study was to assess the safety of cabergoline regarding cardiac valvular status during prospective follow-up in patients treated for prolactinoma or idiopathic hyperprolactinemia. We report here a series of 100 patients (71F; median age at diagnosis: 41.5 years) treated with cabergoline for endocrine diseases (prolactinoma n = 89, idiopathic hyperprolactinemia n = 11). All patients underwent complete transthoracic echocardiographic studies at baseline and during long-term prospective surveillance using the same equipment and performed by the same technicians. The median interval between baseline and last follow-up echocardiographic studies while on cabergoline was 62.5 months (interquartile range: 34.75-77.0). The median total duration of cabergoline treatment was 124.5 months (interquartile range: 80.75-188.75) and the median cumulative total dose of cabergoline was 277.8 mg (interquartile range : 121.4-437.8 mg) at last follow-up. We found no clinically relevant alterations in cardiac valve function or valvular calcifications with cabergoline treatment. Our data suggest that findings from retrospective analyses are correct and that cabergoline is a safe chronic treatment at the doses used typically in endocrinology. [less ▲]

Detailed reference viewed: 14 (2 ULg)
Full Text
See detailQuantitative Three-Dimensional Color Flow Echocardiography of Chronic Mitral Regurgitation: New Methods, New Perspectives, New Challenges
zhou, x; vannan, m; LANCELLOTTI, Patrizio ULg

in Journal of the American Society of Echocardiography (2016), 29(10), 935-937

Detailed reference viewed: 5 (0 ULg)
See detailHeart Team Liege - Session Video Link
PIERARD, Luc ULg; vahanian, Alec; LANCELLOTTI, Patrizio ULg et al

Conference (2016, September)

Detailed reference viewed: 69 (1 ULg)
See detailHeart Team Session
PIERARD, Luc ULg; LANCELLOTTI, Patrizio ULg; PETERMANS, Jean ULg et al

Conference (2016, August)

Detailed reference viewed: 23 (3 ULg)
Full Text
See detailSTRESS (EXERCISE) ECHOCARDIOGRAPHY in asymptomatic AORTIC STENOSIS
LANCELLOTTI, Patrizio ULg; DULGHERU, Raluca Elena ULg

in ASE's comprehensive echocardiography, second edition (2016)

Detailed reference viewed: 30 (3 ULg)
Full Text
See detailMalignant Mitral Valve Prolapse: Substrates to Ventricular Remodeling and Arrhythmias.
LANCELLOTTI, Patrizio ULg; Garbi, Madalina

in Circulation: Cardiovascular Imaging (2016), 9(8), 005248

Detailed reference viewed: 19 (3 ULg)
Full Text
See detailRoLE OF EXERCISE STRESS TESTING
LANCELLOTTI, Patrizio ULg; MOONEN, Marie ULg; magne, Julien

in ASE's comprehensive echocardiography, second edition (2016)

Detailed reference viewed: 21 (4 ULg)
Full Text
See detailSTRESS ECHOCARDIOGRAPHY FOR VALVE DISEASE/: AORTIC REGURGITATION AND MITRAL STENOSIS
LANCELLOTTI, Patrizio ULg; MAGNE, Julien

in ASE's comprehensive echocardiography, second edition (2016)

Detailed reference viewed: 18 (0 ULg)
Full Text
See detailNormal reference values for echocardiography: a call for comparison between ethnicities.
Cosyns, Bernard; LANCELLOTTI, Patrizio ULg

in European Heart Journal - Cardiovascular Imaging (2016), 17(5), 523-4

Detailed reference viewed: 21 (6 ULg)
Full Text
See detailPredicting Reversibility of Anticancer Drugs-Related Cardiac Dysfunction: A New Piece to the Routine Use of Deformation Imaging.
Lancellotti, Patrizio ULg; Moonen, Marie; Jerusalem, Guy ULg

in Echocardiography (Mount Kisco, N.Y.) (2016), 33(4), 504-9

Detailed reference viewed: 21 (2 ULg)
Full Text
See detailTargeting the tricuspid valve: A new therapeutic challenge.
LANCELLOTTI, Patrizio ULg; Fattouch, Khalil; DULGHERU, Raluca Elena ULg

in Archives of cardiovascular diseases (2016)

Detailed reference viewed: 29 (8 ULg)
See detailASSESSMENT OF SECONDARY MITRAL REGURGITATION
DULGHERU, Raluca Elena ULg; INCARNATE, Pierluigui; LANCELLOTTI, Patrizio ULg

in CURRENT APPROACH TO HEART FAILURE (2016)

Detailed reference viewed: 13 (0 ULg)
See detailTHE EACVI ECHOCARDIOGRAPHY TEXTBOOK - SECOND EDITION
LANCELLOTTI, Patrizio ULg; ZAMORANO; HABIB et al

Book published by Oxford University Press (2016)

Detailed reference viewed: 6 (0 ULg)
Full Text
See detailQuantification of paravalvular regurgitation after transcatheter aortic valve implantation: improved accuracy means better standardization.
Lancellotti, Patrizio ULg; Piazza, Nicolo; Modine, Thomas

in European Heart Journal - Cardiovascular Imaging (2016)

Detailed reference viewed: 7 (0 ULg)
Full Text
See detailThe clinical challenge of concomitant aortic and mitral valve stenosis.
Unger, Philippe; Lancellotti, Patrizio ULg; de Canniere, Didier

in Acta Cardiologica (2016), 71(1), 3-6

The coexistence of mitral and aortic stenosis is not exceptional. Whereas rheumatic fever is currently plummeting in the Western countries, the incidence of degenerative disease is inversely increasing ... [more ▼]

The coexistence of mitral and aortic stenosis is not exceptional. Whereas rheumatic fever is currently plummeting in the Western countries, the incidence of degenerative disease is inversely increasing. The haemodynamic interactions which may interfere both with the usual echocardiographic parameters and with the invasive assessment may render the diagnosis difficult. The therapeutic challenges raised by this entity should not be underestimated. The increased morbidity and mortality of multivalvular surgery has to be balanced with the risk of a second operation down the line if one valvular involvement, deemed of a lesser importance, is neglected. This complex situation requires the multidisciplinary approach of a heart team involving surgeons, cardiologists, geriatrists if need be and imaging specialists. [less ▲]

Detailed reference viewed: 12 (0 ULg)